Despite reactive astrogliosis being a common pathological hallmark in both frontotemporal dementia and Alzheimer’s disease, significant differences were observed regarding blood GFAP level suggest that astrogliosis may differ between these pathologies. This evidence concerns the gene GFAP and early-onset autosomal dominant Alzheimer disease.